Markets:

Overview

News

Currencies

International

Treasuries

Black Diamond Therapeutics, Inc. - Common Stock (NQ:BDTX)

2.670 -0.040 (-1.48%)

Streaming Delayed Price Updated: 4:00 PM EST, Dec 5, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Black Diamond Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

What 6 Analyst Ratings Have To Say About Black Diamond Therapeutic ↗

September 12, 2023

Via Benzinga

Black Diamond Therapeutics Announces First Patients Dosed in Phase 1 Clinical Trial Expansion Cohorts Evaluating BDTX-1535 in Patients with Intrinsic Driver and Acquired Resistance EGFR Mutation Positive Non-Small Cell Lung Cancer

September 11, 2023

From Black Diamond Therapeutics, Inc

Via GlobeNewswire

Black Diamond Therapeutics to Participate in Upcoming Investor Conferences

September 05, 2023

From Black Diamond Therapeutics, Inc

Via GlobeNewswire

Black Diamond Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update

August 11, 2023

From Black Diamond Therapeutics, Inc

Via GlobeNewswire

Where Black Diamond Therapeutic Stands With Analysts ↗

July 14, 2023

Via Benzinga

What 4 Analyst Ratings Have To Say About Black Diamond Therapeutic ↗

June 28, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For July 14, 2023 ↗

July 14, 2023

Via Benzinga

$4.7M Bet On Black Diamond Therapeutics? Check Out These 3 Stocks Insiders Are Buying ↗

July 10, 2023

Although US stocks closed lower on Friday, there were a few notable insider trades.

Via Benzinga

Nanobiotix, NanoString Technologies And Other Big Stocks Moving Higher In Monday's Pre-Market Session ↗

July 10, 2023

U.S. stock futures traded lower this morning. Here are some big stocks recording gains in today’s pre-market trading session.

Via Benzinga

Why Icahn Enterprises Shares Are Trading Higher By 18%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

July 10, 2023

Gainers Mobilicom Limited (NASDAQ: MOB) shares jumped 81.3% to $2.7187 after the company announced it received a commercial scale purchase order from Teledyne-FLIR for the production of drones for the...

Via Benzinga

$1M Bet On Children's Place? Check Out These 3 Stocks Insiders Are Buying ↗

July 07, 2023

Although US stocks closed lower on Thursday, there were a few notable insider trades.

Via Benzinga

$5M Bet On This Biotechnology Stock? Check Out These 3 Stocks Insiders Are Buying ↗

July 05, 2023

Although US stocks closed slightly higher on Monday, there were a few notable insider trades.

Via Benzinga

Genuine Monotherapy Approach In EGFRm NSCLC: Analyst Upgrades Switches To Buy On Black Diamond Therapeutics ↗

June 30, 2023

Tuesday, Black Diamond Therapeutics Inc (NASDAQ: BDTX) announced initial clinical data from the dose escalation portion of Phase 1 clinical study of BDTX-1535 for non-small cell lung cancer (NSCLC)

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For June 30, 2023 ↗

June 30, 2023

Via Benzinga

$1.5M Bet On ONEOK? Check Out These 3 Stocks Insiders Are Buying ↗

June 30, 2023

Although US stocks closed mostly higher on Thursday, there were a few notable insider trades.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

June 30, 2023

It's the final day of trading this week and we're starting off with a breakdown of the biggest pre-market stock movers worth watching today!

Via InvestorPlace

Black Diamond Therapeutics Announces Pricing of Public Offering of Common Stock

June 29, 2023

From Black Diamond Therapeutics, Inc

Via GlobeNewswire

Why Shares of Black Diamond Therapeutics Skyrocketed This Week ↗

June 29, 2023

The company announced positive early-trial news for non-small cell lung cancer.

Via The Motley Fool

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

June 29, 2023

Via Benzinga

Why CorMedix Are Trading Lower By 22%; Here Are 20 Stocks Moving Premarket ↗

June 29, 2023

Gainers Eco Wave Power Global AB (NASDAQ: WAVE) shares surged 123% to $3.48 in pre-market trading after dropping over 8% on Wednesday.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

June 29, 2023

We're starting Thursday with a detailed look at all of the biggest pre-market stock movers worth keeping an eye on today!

Via InvestorPlace

Black Diamond Therapeutics Announces Proposed Public Offering of Common Stock

June 28, 2023

From Black Diamond Therapeutics, Inc

Via GlobeNewswire

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

June 28, 2023

Via Benzinga

Why Eton Pharmaceuticals Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

June 28, 2023

Gainers Minerva Neurosciences, Inc. (NASDAQ: NERV) surged 46.2% to $8.80. Minerva Neurosciences announced $20 million in private placement priced at a premium to market.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For June 28, 2023 ↗

June 28, 2023

Via Benzinga

Tesla And Nvidia Lead The Charge As Stocks Surge: Top Trends Of The Day ↗

June 27, 2023

Via Benzinga

Nasdaq Jumps Over 200 Points; TD Synnex Posts Downbeat Results ↗

June 27, 2023

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 200 points on Tuesday. The Dow traded up 0.73% to 33,959.64 while the NASDAQ rose 1.75% to 13,569.42....

Via Benzinga

Why Walgreens Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

June 27, 2023

Gainers Tivic Health Systems, Inc. (NASDAQ: TIVC) shares jumped 105% to $0.2050 after the company signed a distribution agreement with Cardinal Health.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

June 27, 2023

Via Benzinga

Black Diamond Therapeutics’ (NASDAQ: BDTX) BDTX-1535 Proves Promising for EGFR Mutated NSCLC and GBM

June 27, 2023

Black Diamond Therapeutics has announced encouraging initial data from a Phase 1 study of BDTX-1535, an investigational fourth-generation EGFR MasterKey

Via Spotlight Growth

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.